Fatty liver disease impacts millions and is becoming increasingly prevalent alongside rising obesity and diabetes rates. In its early stages, many individuals experience no symptoms, but if left unmanaged, the condition can advance to liver inflammation, scarring, and ultimately liver failure.
Diet significantly influences the development of fatty liver, yet researchers are still determining which foods help and which might contribute to the problem. A recent study from Edith Cowan University sheds new light by exploring two nutrients that have gained popularity for different reasons. The findings were published in Molecular Nutrition and Food Research and focused on ellagic acid, a natural compound present in fruits and nuts, and inulin, a fiber supplement commonly used to support gut health.
Ellagic acid naturally occurs in pomegranates, strawberries, raspberries, grapes, and walnuts. It’s studied for its antioxidant and anti-inflammatory effects, which may protect organs from long-term damage. In the research, scientists tested these substances on mice suffering from non-alcoholic steatohepatitis, a severe form of fatty liver disease. The results showed that ellagic acid helped shield the liver and diminished disease indicators, making it a promising candidate for further research.
Conversely, the effects of inulin were unexpected. Despite its reputation as a prebiotic that promotes healthy gut bacteria, the supplement increased weight gain, elevated blood sugar levels, and worsened liver damage in the mouse model. Researchers believe these adverse effects may stem from alterations in the gut microbiome. This suggests that the health impacts of dietary supplements can vary depending on the specific disease context and the overall dietary balance.
The authors emphasized that people shouldn’t stop consuming fiber-rich foods like fruits, vegetables, and whole grains based on this study alone. The findings relate specifically to a particular supplement tested under experimental conditions, not to naturally fiber-rich whole foods. More human studies are essential to verify if these results hold true for people with fatty liver disease. If future research confirms these findings, medical professionals might become more selective about recommending certain natural foods or supplements.
The study provides early but valuable insights, though it remains preliminary since it was conducted on mice, not humans. Its strength lies in analyzing both beneficial and potentially harmful dietary components simultaneously. Overall, the results highlight that supplements aren’t always risk-free and that consuming whole foods with natural plant compounds may be safer for long-term health.
For those concerned about liver health, exploring dietary strategies, including the potential benefits of coffee in reducing liver cancer risk, is advisable. Additional recent studies suggest that an anti-inflammatory diet could help prevent fatty liver disease, and vitamin D might also play a protective role against non-alcoholic fatty liver disease.
Source: Edith Cowan University.